TITLE:
Study Evaluating of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in Liver Transplant Recipients

CONDITION:
Liver Transplantation

INTERVENTION:
Sirolimus (Rapamune)

SUMMARY:

      The purpose of this study is to evaluate the sirolimus conversion regimen as compared with
      the calcineurin inhibitor continuation regimen with regards to renal function in stable
      liver transplant subjects.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 13 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Age greater than 13 years (age greater than 18 years as required by some local
             regulations).

          -  Receiving immunosuppressive therapy with calcineurin inhibitors (CI) +/-
             corticosteroids +/- antimetabolite.

          -  6 to 144 months after orthotopic liver transplantation.

          -  Cockcroft-Gault GFR values 40 mL/min and 90mL/min at screening

        Exclusion Criteria:

          -  History of nonhepatic transplantation

          -  Evidence of systemic infection (sepsis, bacteremia, pneumonia etc).

          -  Known or suspected malignancy < 5 years before random assignment.
      
